New approach could improve survival time for pancreatic cancer patients
A University of Liverpool-led clinical trial has shown that 29% of pancreatic cancer patients given a combination of two chemotherapy drugs lived for at least five years compared with 16% who received the one chemotherapy drug (University of Liverpool, 2017). The latest Cancer Research UK figures show that around 9,400 people are diagnosed with pancreatic … Continue reading New approach could improve survival time for pancreatic cancer patients
University of Liverpool and Crypalis to develop acute pancreatitis drug
A partnership between the University of Liverpool and Cypralis has been granted a new Early Stage Award worth £300,000 to develop new compounds to treat acute pancreatitis (University of Liverpool, 2017). Acute pancreatitis is an extremely painful disease that is most often associated with gallstones, excessive alcohol intake and obesity and is currently treated in … Continue reading University of Liverpool and Crypalis to develop acute pancreatitis drug
Blood test can predict life or death outcome for patients with Ebola virus
Scientists have identified a molecular barcode in the blood of patients with the Ebola virus that can predict whether they are likely to survive or die (University of Liverpool, 2017). A team at the University of Liverpool, in collaboration with Public Health England, Boston University and other international partners, used blood samples taken from infected … Continue reading Blood test can predict life or death outcome for patients with Ebola virus
Centre of Excellence in Infectious Disease Research launched
The University of Liverpool and Liverpool School of Tropical Medicine (LSTM) have launched a new joint centre which aims to address the urgent need to develop new antimicrobials and accelerate solutions for existing and emerging infections (University of Liverpool, 2017). Translating research from across these two institutions, the Centre of Excellence in Infectious Diseases Research … Continue reading Centre of Excellence in Infectious Disease Research launched
£1.5m boost for cancer research in Liverpool
Liverpool scientists and doctors are set to receive a major cash boost for research into cancer (University of Liverpool, 2017). Cancer Research UK and NIHR plan to invest nearly £1.5m over the next five years in ground-breaking work at the Liverpool Experimental Cancer Medicine Centre (ECMC). The ECMC is a collaboration between researchers at the … Continue reading £1.5m boost for cancer research in Liverpool
Scientists trial a living bandage for knee injuries
A living bandage made from stem cells, which could revolutionise the treatment and prognosis of meniscal tears, a common sporting knee injury, has been trialled in humans for the first time by scientists at the Universities of Bristol and Liverpool (University of Bristol, 2016). Meniscal tears are suffered by over one million people a year … Continue reading Scientists trial a living bandage for knee injuries
